Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1

Status

Unknown 3Completed 2Terminated 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Gynecologic 1

Conditions

Anemia 2Uterine Cervical Neoplasms 1Radiation Injuries 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cyclophosphamide 298Cisplatin 298Paclitaxel 257Radiotherapy 254Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 214Dexamethasone 166Gemcitabine 156Vincristine 145Etoposide 135Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Erythropoietin × Clear all
NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

GOG Foundation

Phase 3 Completed
114 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT02767765 2017-04-04

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Hoffmann-La Roche

Phase 3 Completed
61 enrolled 11 charts
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡